Stock listing

Insulet Corporation

Selected listing: 0ADR · LSE · USD · GB

Insulet Corporation (LSE:0ADR), Health Technology. Latest release Oct 1, 2026: Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026.

0ADR:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0ADR
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LSE
Currency: USD

About Insulet Corporation

The company specializes in innovative diabetes management solutions, particularly its Omnipod insulin management system. Insulet is committed to improving the lives of individuals with diabetes through advanced technology and patient-centered care.

Latest news from Insulet Corporation

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

September 30, 2026

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 1, 2026

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

September 18, 2026

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

August 26, 2026

Insulet Reports Second Quarter 2026 Results

August 5, 2026

All Insulet Corporation news →

Events

Replays

Insulet Corporation (PODD) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 08:00 AM ET
Watch
Insulet Corporation (PODD) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:00 AM ET
Watch
Insulet Corporation (PODD) Q4 2025 Earnings Call
Wed, Feb 18, 2026 · 08:00 AM ET
Watch

Research Insulet Corporation

Insulet Corporation company profile

View the public company page for Insulet Corporation on 6ix.

Insulet Corporation news

Read company news and market updates connected to Insulet Corporation.

Insulet Corporation investor events

Find investor webinars, events, and replay context for Insulet Corporation.